ARQT - Arcutis Biotherapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARQT is currently covered by 9 analysts with an average price target of $26.26. This is a potential upside of $17.1 (186.68%) from yesterday's end of day stock price of $9.16.

Arcutis Biotherapeutics 's activity chart (see below) currently has 27 price targets and 60 ratings on display. The stock rating distribution of ARQT is 85% BUY and 15% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.97% with an average time for these price targets to be met of 43.69 days.

Highest price target for ARQT is $18, Lowest price target is $6, average price target is $26.26.

Most recent stock forecast was given by UY EAR from MIZUHO on 15-May-2024. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 34 are a BUY (85%), 6 are a HOLD (15%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

18

$8.84 (96.51%)

17

11 days ago

2/16 (12.5%)

$8.76 (94.81%)

58

Buy

18

$8.84 (96.51%)

16

11 days ago

1/11 (9.09%)

$8.76 (94.81%)

102

Hold

11

$1.84 (20.09%)

6

2 months 28 days ago

2/4 (50%)

$0.59 (5.67%)

55

Buy

11

$1.84 (20.09%)

10

5 months 5 days ago

2/8 (25%)

$8.4 (323.08%)

89

Buy

10

$0.84 (9.17%)

45

6 months 13 days ago

1/3 (33.33%)

$7.89 (373.93%)

106

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?

On average it took 43.69 days on average for the stock forecasts to be realized with a an average price target met ratio 18.97

Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh works at MIZUHO and has 3 price targets and 2 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?

Louise Chen with highest potential upside - $40.84

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?

Chris Shibutani with lowest potential downside - -$3.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?